SM
VANI icon

Sabby Management’s Vivani Medical VANI Stock Holding History

Sabby Management’s Portfolio VANI Stock Details VANI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-711
Closed -$348K – 193
2021
Q4 		$348K Hold
711
– – 0.05% 122
2021
Q3 		$680K Buy
+711
New +$8.01K 0.09% 107

Other funds holding VANI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TWM
Tanager Wealth Management Goring On Thames, United Kingdom $1.15B AUM 19.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
MMG
Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Sabby Management's VANI Position: Q3 2025 in Review

Sabby Management sold out of Vivani Medical (VANI) in Q3 2025, closing a stake of 93,825 shares — an estimated $121K sold.

Sabby Management first reported a position in VANI in Q1 2021 and held it in 10 quarters. The position peaked at $7.61M in Q1 2021. 29 funds tracked by Wall St. Rank hold VANI as of Q3 2025.

  • Sabby Management reported no remaining Vivani Medical position as of Q3 2025 after selling out during the quarter.
  • Sabby Management sold 93,825 Vivani Medical shares in Q3 2025, an estimated $121K.
  • Sabby Management first reported a position in Vivani Medical in Q1 2021 and held it in 10 quarters.
  • Sabby Management's Vivani Medical position peaked at $7.61M in Q1 2021.
  • 29 funds tracked by Wall St. Rank held Vivani Medical as of Q3 2025.

Based on Sabby Management's 13F filing for Q3 2025, filed 14 Nov 2025.